107 related articles for article (PubMed ID: 30277131)
1. IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model.
Wu X; Hsu DK; Wang KH; Huang Y; Mendoza L; Zhou Y; Hwang ST
Leuk Lymphoma; 2019 May; 60(5):1244-1252. PubMed ID: 30277131
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
[TBL] [Abstract][Full Text] [Related]
3. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
Chang TP; Poltoratsky V; Vancurova I
J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335
[TBL] [Abstract][Full Text] [Related]
5. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
7. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.
Geskin LJ; Viragova S; Stolz DB; Fuschiotti P
Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470
[TBL] [Abstract][Full Text] [Related]
9. A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL).
Wu X; Singh R; Hsu DK; Zhou Y; Yu S; Han D; Shi Z; Huynh M; Campbell JJ; Hwang ST
J Invest Dermatol; 2020 Jul; 140(7):1390-1400.e4. PubMed ID: 31945344
[TBL] [Abstract][Full Text] [Related]
10. Mast cells play a protumorigenic role in primary cutaneous lymphoma.
Rabenhorst A; Schlaak M; Heukamp LC; Förster A; Theurich S; von Bergwelt-Baildon M; Büttner R; Kurschat P; Mauch C; Roers A; Hartmann K
Blood; 2012 Sep; 120(10):2042-54. PubMed ID: 22837530
[TBL] [Abstract][Full Text] [Related]
11. Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.
Wu X; Wang TW; Lessmann GM; Saleh J; Liu X; Chitambar CR; Hwang ST
J Invest Dermatol; 2015 Mar; 135(3):877-884. PubMed ID: 25371972
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
Han Z; Wu X; Qin H; Yuan YC; Schmolze D; Su C; Zain J; Moyal L; Hodak E; Sanchez JF; Lee PP; Feng M; Rosen ST; Querfeld C
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427589
[TBL] [Abstract][Full Text] [Related]
13. Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.
Wu X; Schulte BC; Zhou Y; Haribhai D; Mackinnon AC; Plaza JA; Williams CB; Hwang ST
J Invest Dermatol; 2014 Nov; 134(11):2814-2822. PubMed ID: 24780929
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
Gaydosik AM; Queen DS; Trager MH; Akilov OE; Geskin LJ; Fuschiotti P
Blood; 2020 Oct; 136(15):1748-1759. PubMed ID: 32438399
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of inflammatory cytokines and oncogenic signal pathways preceding tumor formation in a murine model of T-cell lymphoma in skin.
Wu X; Sells RE; Hwang ST
J Invest Dermatol; 2011 Aug; 131(8):1727-34. PubMed ID: 21490619
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
[TBL] [Abstract][Full Text] [Related]
18. Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
Mishra A; La Perle K; Kwiatkowski S; Sullivan LA; Sams GH; Johns J; Curphey DP; Wen J; McConnell K; Qi J; Wong H; Russo G; Zhang J; Marcucci G; Bradner JE; Porcu P; Caligiuri MA
Cancer Discov; 2016 Sep; 6(9):986-1005. PubMed ID: 27422033
[TBL] [Abstract][Full Text] [Related]
19. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
20. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]